4,7-Bis(5-bromothiophen-2-yl)benzo[c][1,2,5]thiadiazole

Catalog No. :
ACZKCD649
CAS No. :
288071-87-4
Molecular Formula :
C14H6Br2N2S3
Molecular Weight :
458.23

IUPAC Name:4,7-bis(5-bromothiophen-2-yl)benzo[c][1,2,5]thiadiazole

4,7-Bis(5-bromothiophen-2-yl)benzo[c][1,2,5]thiadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$91.00Login to see priceIn stockIn stock
5g95%$324.00Login to see priceIn stockIn stock
25g95%$1099.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,7-Bis(5-bromothiophen-2-yl)benzo[c][1,2,5]thiadiazole
IUPAC Name4,7-bis(5-bromothiophen-2-yl)benzo[c][1,2,5]thiadiazole
MDL No.MFCD16619295
Molecular FormulaC14H6Br2N2S3
Molecular Weight458.23
SMILESBrC1=CC=C(C2=CC=C(C3=CC=C(Br)S3)C4=NSN=C42)S1
InChI KeyZIIMIGRZSUYQGW-UHFFFAOYSA-N
SynonymDTXSID90625302 | SB66784 | SCHEMBL13902141 | AKOS016011667 | SY053018 | 4,7-Bis(5-bromothiophen-2-yl)benzo[c][1,2,5]thiadiazole | 4,7-bis(5-bromothien-2-yl)-2,1,3-benzothiadiazole | SCHEMBL680041 | AC-33742 | 4,7-Bis(5-bromothiophen-2-yl)-2,1,3-benzothiad
CAS No.288071-87-4
PubChem CID22381654

Safety Data

Pictogram
CorrosiveToxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H318
Precautionary Statement(s)
P280-P301+P310-P305+P351+P338

Synthetic Route by SureRoute

1. ACZKCD649 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJOEA458 route compound structure diagram
    ACJOEA458165190-76-1 In Stock
  2. Then
  3. ACZKCD649 route product structure diagram
    ACZKCD649288071-87-4 In Stock
Inquiry

2. ACZKCD649 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZKCD649 route product structure diagram
    ACZKCD649288071-87-4 In Stock
Inquiry

Comments (0)